Journal article

A polycistronic retroviral vector encoding hB7-1 (CD80) and hIL-2 for ex vivo cancer gene therapy.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Kuiper, M., GaleaLauri, J., Darling, D., Farzaneh, F., & Gaken, J. (1996). A polycistronic retroviral vector encoding hB7-1 (CD80) and hIL-2 for ex vivo cancer gene therapy. IMMUNOLOGY, 89, B10–B10.

MLA Style

Kuiper, M, et al. “A Polycistronic Retroviral Vector Encoding hB7-1 (CD80) and HIL-2 for Ex Vivo Cancer Gene Therapy.” IMMUNOLOGY, vol. 89, 1996, pp. B10–B10.

Chicago Style

Kuiper, M, J GaleaLauri, D Darling, F Farzaneh, and J Gaken. 1996. “A Polycistronic Retroviral Vector Encoding hB7-1 (CD80) and HIL-2 for Ex Vivo Cancer Gene Therapy.” IMMUNOLOGY 89: B10–B10.
Print

Authors

+ Kuiper, M More by this author

Role:: Author

+ GaleaLauri, J More by this author

Role:: Author

+ Darling, D More by this author

Role:: Author

+ Farzaneh, F More by this author

Role:: Author

+ Gaken, J More by this author

Role:: Author

Journal:: IMMUNOLOGY More from this journal
Volume:: 89
Pages:: B10-B10
Publication date:: 1996-11-01
ISSN:: 0019-2805

Pubs id:: pubs:466418
UUID:: uuid:087599b6-b3af-4ea6-950a-55bad13ba80e
Local pid:: pubs:466418
Source identifiers:: 466418
Deposit date:: 2014-06-18
ARK identifier:: ark:/29072/ora_087599b6b3af4ea6950a55bad13ba80e

Terms of use

Copyright date:: 1996

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP